84 related articles for article (PubMed ID: 22523302)
1. heterogeneity of dna ploidy in endometrial carcinoma: comparison of different tissue samples obtained during diagnosis and treatment.
Libalova P; Vernerova Z; Hubickova-Heringova L; Pinterova D; Kolostova K; Bobek V; Tikovsky K; Housa D; Kubecova M; Pecen L; Svoboda B
In Vivo; 2012; 26(3):473-80. PubMed ID: 22523302
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy heterogeneity in endometrial carcinoma: comparison between curettage and hysterectomy specimens.
Pradhan M; Abeler VM; Davidson B; Kildal W; Nybøen A; Tropé CG; Risberg B; Danielsen HE
Int J Gynecol Pathol; 2010 Nov; 29(6):572-8. PubMed ID: 20881853
[TBL] [Abstract][Full Text] [Related]
3. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric DNA analysis of ulcerative colitis using paraffin-embedded biopsy specimens: comparison with morphology and DNA analysis of fresh samples.
Hartmann DP; Montgomery EA; Carr NJ; Gupta PK; Azumi N
Am J Gastroenterol; 1995 Apr; 90(4):590-6. PubMed ID: 7717317
[TBL] [Abstract][Full Text] [Related]
5. Endometrial carcinomas--flow cytometric DNA content and S-phase values.
Jacobsen M; Jakobsen A; Nedergaard L; Andersen JE; Nielsen K
Pathol Res Pract; 1997; 193(4):283-90. PubMed ID: 9258954
[TBL] [Abstract][Full Text] [Related]
6. [Variability of quantitative DNA parameters in endometrial carcinoma].
Köhler U; Naumann G; Nenning A; Taubert G; Bilek K
Zentralbl Gynakol; 1994; 116(11):609-13. PubMed ID: 7871910
[TBL] [Abstract][Full Text] [Related]
7. Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators.
Lim P; Aquino-Parsons CF; Wong F; Dupuis B; Phillips D; Zhou C; Gilks CB
Gynecol Oncol; 1999 May; 73(2):191-5. PubMed ID: 10329033
[TBL] [Abstract][Full Text] [Related]
8. Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer.
Proctor L; Pradhan M; Leung S; Cheng A; Lee CH; Soslow RA; Gilks CB; Talhouk A; McAlpine JM; Danielsen HE; Hoang LN
Gynecol Oncol; 2017 Sep; 146(3):596-602. PubMed ID: 28647100
[TBL] [Abstract][Full Text] [Related]
9. [Cytophotometric studies for evaluating the prognosis in endometrial cancer].
Köhler U; Krug H; Taubert G
Zentralbl Gynakol; 1991; 113(24):1371-9. PubMed ID: 1808964
[TBL] [Abstract][Full Text] [Related]
10. Preoperative evaluation of tumor ploidy in endometrial carcinoma: An accurate tool to identify patients at risk for extrauterine disease and recurrence.
Susini T; Rapi S; Massi D; Savino L; Amunni G; Taddei GL; Massi G
Cancer; 1999 Sep; 86(6):1005-12. PubMed ID: 10491527
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
Takahashi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
[TBL] [Abstract][Full Text] [Related]
12. [Endometrial carcinoma: prognostic significance of cellular ploidy].
Pasini A; Corbella P; Colombo E; Redaelli L; Belloni C
Minerva Ginecol; 2000 May; 52(5):179-84. PubMed ID: 11048473
[TBL] [Abstract][Full Text] [Related]
13. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
14. Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometrium.
Dyas CH; Simmons TK; Ellis CN; Austin JM; Partridge EE; Kilgore LC; Reading C; Nelson K; Blakemore WS
Surg Gynecol Obstet; 1992 Feb; 174(2):133-6. PubMed ID: 1734571
[TBL] [Abstract][Full Text] [Related]
15. DNA aneuploidy is associated with increased mortality for stage I endometrial cancer.
Terada K; Mattson D; Goo D; Shimizu D
Gynecol Oncol; 2004 Dec; 95(3):483-7. PubMed ID: 15581950
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
Shimizu K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
[TBL] [Abstract][Full Text] [Related]
17. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.
Santala M; Talvensaari-Mattila A
Anticancer Res; 2003; 23(6D):5191-6. PubMed ID: 14981988
[TBL] [Abstract][Full Text] [Related]
18. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell cycle in patients with stage I endometrial carcinoma.
Vecek N; Nola M; Marusić M; Babić D; Uzarević B; Sabioncello A; Petrovecki M; Ljubić-Racunica N; Marinović T
Gynecol Oncol; 1994 Apr; 53(1):38-43. PubMed ID: 8175020
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of DNA ploidy in fresh tumor tissues to prognosis of nasopharyngeal carcinoma].
Han F; Wang HY; Xia YF; Liu MZ; Zhao C; Lu TX
Ai Zheng; 2007 Sep; 26(9):1015-9. PubMed ID: 17927864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
